Fig. 4From: Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysisCumulative meta-analysis of the biochemical cure rate (a) and recurrence rate (b) in prolactinoma patients subgrouped by the treatment methodsBack to article page